MIDDLE-EAST AND AFRICA BLOOD GLUCOSE MONITORING MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)

MIDDLE-EAST AND AFRICA BLOOD GLUCOSE MONITORING MARKET - GROWTH, TRENDS, COVID-19 IMPACT, AND FORECASTS (2022 - 2027)

Middle-East and Africa Blood Glucose Monitoring Devices Market are expected to register a CAGR greater than 10% over the forecast period, 2022-2027. The market is estimated to reach above USD 630 million by 2027.

Diabetes and COVID-19 have a significant influence on public health not just overseas but also in the Middle East and Africa. In COVID-19 patients, diabetes has been reported to increase the incidence of both fatal infections and serious infections. Because diabetes is one of the primary health issues that is incredibly prevalent in the Middle East and African countries, the present research focused on understanding the epidemiology of COVID-19 in people with diabetes and the initiatives put in place by the governments to decrease its impact.

There is an increasing incidence of lifestyle diseases, such as diabetes, in developing countries that are increasing the demand for blood glucose monitoring devices. The increased awareness about healthcare facilities and preventive care is also supporting the growth of the market. The number of patients relying on self-monitoring blood glucose (SMBG) has increased. Owing to the high-cost constraints associated with continuous glucose monitoring (CGM), self-monitoring by glucometer is more acceptable in the Middle-East and Africa region. These devices help in the early detection of hypo and hyperglycemia conditions, which tend to drive the market for glucose monitoring.

Key Market TrendsTest Strips Accounted for The Highest Market Share in Middle-East And Africa Blood Glucose Monitoring Devices Market.

In the Middle-East and Africa blood glucose monitoring devices market, test strips hold 45% of the share with USD 136 million in revenue. Price is often a significant concern in the purchase of blood glucose test strips. Although various countries provide reimbursements for prescribed test strips, a majority of the patients have to pay for them from their pockets. Africa is experiencing a rise in the number of diabetic patients over the past decade. Total diabetes-related health expenditure in Africa is close to USD 9,500 million, which is expected to almost double by 2045.

Programs, such as the Base of the Pyramid project, a public-private partnership initiated by Novo Nordisk aim to increase awareness about diabetes in low- and middle-income countries in Africa.​ In the Middle-East and Africa, due to lifestyle and food habits, blood glucose fluctuations among insulin users are frequent from time to time, and the usage of self-monitoring of blood glucose increases. ​

A rise in the diabetic population drives the market by increasing the use of blood glucose monitoring devices. Obesity is considered one of the major factors contributing to the disease, primarily Type 2 diabetes. Also, other factors, such as technological innovations and advancements, give many conveniences in measuring blood glucose levels. One such advancement in monitoring the blood glucose level is established with continuous glucose monitoring devices. Therefore, due to an increase in the usage of monitoring devices among the type-2 diabetes population the market is expected to grow.

Saudi Arabia and Iran Together Accounted for over 50% Share in the Middle-East and Africa Blood Glucose Monitoring Devices Market.

Diabetes is one of the mounting health problems the country is facing. Saudi is ranked among the top three in the Middle-East and African countries with the highest prevalence of diabetes. The diabetes population in Saudi Arabia increased from 1.48 million in 2012 to 5.95 million in 2021 and is expected to reach more than 8 million by 2027. The type-1 diabetes population in the country is projected to reach more than 0.5 million by 2027 from 0.39 million in 2021.

The leading market in the Middle-East and Africa Blood Glucose Monitoring Devices Market is Saudi Arabia with a 36% market share followed by Iran and others. The high sales of Blood Glucose Monitoring Devices in Saudi Arabia are due to the growing prevalence of diabetes in the country. The Middle-East countries have high diabetes prevalence like Saudi Arabia at 24%, Kuwait at 23%, Bahrain at 22%, Qatar at 20%, and UAE at 19% approximately. Price is often a significant concern in the purchase of Blood Glucose Monitoring Devices. Although various countries, like Saudi Arabia, Iran, and other countries in Middle-East and Africa provide reimbursements for prescribed SMBG devices and their components, most of the patients have to pay for them from their pockets.

Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in Middle-East and Africa Region.

Competitive Landscape

The Middle-East and Africa blood glucose monitoring market is highly fragmented with few major manufacturers boasting a global market presence, while the remaining manufacturers are confined to the other local or region-specific manufacturers, and the local government initiatives encourage the market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.